Desidustat

Generic Name
Desidustat
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C16H16N2O6
CAS Number
1616690-16-4
Unique Ingredient Identifier
Y962PQA4KS
Background

Desidustat is under investigation in clinical trial NCT04012957 (Desidustat in the Treatment of Anemia in CKD).

Associated Conditions
-
Associated Therapies
-

A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)

First Posted Date
2022-08-25
Last Posted Date
2023-12-26
Lead Sponsor
Zydus Lifesciences Limited
Target Recruit Count
1004
Registration Number
NCT05515367
Locations
🇮🇳

Indira Gandhi Institute of Medical Sciences, Sheikhpura, Bihar, India

Desidustat in the Treatment of Chemotherapy Induced Anemia

First Posted Date
2020-12-14
Last Posted Date
2022-05-18
Lead Sponsor
Zydus Lifesciences Limited
Target Recruit Count
24
Registration Number
NCT04667533
Locations
🇮🇳

HCG Manavata Cancer Centre,, Nashik, Mahar Ashtra, India

Desidustat in the Management of COVID-19 Patients

Phase 2
Completed
Conditions
Interventions
First Posted Date
2020-07-09
Last Posted Date
2021-04-23
Lead Sponsor
Zydus Lifesciences Limited
Target Recruit Count
24
Registration Number
NCT04463602
Locations
🇲🇽

Avant Sante Site 1, Monterrey, Mexico

© Copyright 2024. All Rights Reserved by MedPath